Concepedia

Vicki Klutzaritz

VK

Statistics

Publications

4

Citations

114

H-Index

4

Active since

2011

Affiliations

Cassava Sciences (United States)(Current)

University of Nevada, Las Vegas

Cognitive Research (United States)

Vicki Klutzaritz is an author at Cassava Sciences (United States) specializing in alzheimer disease dementia, pharmacological treatment of dementia, and medicine.

Publications per year

2011–2021

4

Publications

4

Safety and Efficacy of 188-Rhenium-Labeled Antibody to Melanin in Patients with Metastatic Melanoma

Marc Klein, Michal Lotem, Tamar Peretz et al. · Journal of Skin Cancer · 2013 · 43 citations · Full text

, , +16

Long-Term Safety of Remoxy<sup>®</sup>(Extended-Release Oxycodone) in Patients with Moderate to Severe Chronic Osteoarthritis or Low Back Pain

N. Friedmann, Vicki Klutzaritz, Lynn R. Webster · Pain Medicine · 2011 · 32 citations · Full text

, , +16

Safety and Tolerability of GRF6019 Infusions in Severe Alzheimer’s Disease: A Phase II Double-Blind Placebo-Controlled Trial

Jonas Hannestad, Tiffanie Duclos, Whitney Chao et al. · Journal of Alzheimer s Disease · 2021 · 22 citations

, , +17

Safety and tolerability of GRF6019 in mild‐to‐moderate Alzheimer's disease dementia

Jonas Hannestad, Katie Koborsi, Vicki Klutzaritz et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions · 2020 · 17 citations · Full text

, , +13

1–4 of 4